NO137897C - Fremgangsmaate til fremstilling av optisk aktive 1,4-benzdiazepin-2-on-derivater - Google Patents

Fremgangsmaate til fremstilling av optisk aktive 1,4-benzdiazepin-2-on-derivater

Info

Publication number
NO137897C
NO137897C NO742739A NO742739A NO137897C NO 137897 C NO137897 C NO 137897C NO 742739 A NO742739 A NO 742739A NO 742739 A NO742739 A NO 742739A NO 137897 C NO137897 C NO 137897C
Authority
NO
Norway
Prior art keywords
benzdiazepin
derivatives
procedure
optically active
preparing optically
Prior art date
Application number
NO742739A
Other languages
English (en)
Norwegian (no)
Other versions
NO137897B (no
NO742739L (ru
Inventor
Franjo Kajfez
Vitomir Sunjic
Original Assignee
Crc Ricerca Chim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crc Ricerca Chim filed Critical Crc Ricerca Chim
Publication of NO742739L publication Critical patent/NO742739L/no
Publication of NO137897B publication Critical patent/NO137897B/no
Publication of NO137897C publication Critical patent/NO137897C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • C07D243/28Preparation including building-up the benzodiazepine skeleton from compounds containing no hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO742739A 1973-07-30 1974-07-29 Fremgangsmaate til fremstilling av optisk aktive 1,4-benzdiazepin-2-on-derivater NO137897C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1105673A CH573928A5 (ru) 1973-07-30 1973-07-30

Publications (3)

Publication Number Publication Date
NO742739L NO742739L (ru) 1975-02-24
NO137897B NO137897B (no) 1978-02-06
NO137897C true NO137897C (no) 1978-05-16

Family

ID=4369623

Family Applications (1)

Application Number Title Priority Date Filing Date
NO742739A NO137897C (no) 1973-07-30 1974-07-29 Fremgangsmaate til fremstilling av optisk aktive 1,4-benzdiazepin-2-on-derivater

Country Status (21)

Country Link
US (1) US4010153A (ru)
JP (1) JPS5041886A (ru)
AR (1) AR202224A1 (ru)
AT (1) AT337192B (ru)
BE (1) BE818047A (ru)
CA (1) CA1021778A (ru)
CH (1) CH573928A5 (ru)
DE (1) DE2436744A1 (ru)
DK (1) DK138798B (ru)
ES (1) ES428675A1 (ru)
FI (1) FI227474A (ru)
FR (1) FR2239464B1 (ru)
GB (1) GB1481219A (ru)
HU (1) HU169180B (ru)
IE (1) IE39904B1 (ru)
IL (1) IL45289A (ru)
NL (1) NL7410256A (ru)
NO (1) NO137897C (ru)
SE (2) SE7409708L (ru)
SU (1) SU528872A3 (ru)
ZA (1) ZA744635B (ru)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1332410C (en) * 1984-06-26 1994-10-11 Roger M. Freidinger Benzodiazepine analogs
US4820834A (en) * 1984-06-26 1989-04-11 Merck & Co., Inc. Benzodiazepine analogs
LT3324977T (lt) 2015-07-22 2022-10-25 Enanta Pharmaceuticals, Inc. Benzodiazepino dariniai kaip rsv inhibitoriai
WO2017123884A1 (en) 2016-01-15 2017-07-20 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as rsv inhibitors
EP3582784B1 (en) 2017-02-16 2022-06-08 Enanta Pharmaceuticals, Inc. Processes for the preparation of benzodiazepine derivatives
WO2018226801A1 (en) 2017-06-07 2018-12-13 Enanta Pharmaceuticals, Inc. Aryldiazepine derivatives as rsv inhibitors
US10851115B2 (en) 2017-06-30 2020-12-01 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as RSV inhibitors
US11091501B2 (en) 2017-06-30 2021-08-17 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as RSV inhibitors
CN111386118B (zh) 2017-09-29 2023-05-09 英安塔制药有限公司 作为rsv抑制剂的组合药物剂
CA3080138A1 (en) * 2017-11-13 2019-05-16 Enanta Pharmaceuticals, Inc. Processes for the resolution of benzodiazepin-2-one and benzoazepin-2-one derivatives
US10647711B2 (en) 2017-11-13 2020-05-12 Enanta Pharmaceuticals, Inc. Azepin-2-one derivatives as RSV inhibitors
WO2019199908A1 (en) 2018-04-11 2019-10-17 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as rsv inhibitors
CN113710276B (zh) 2019-03-18 2024-03-29 英安塔制药有限公司 苯二氮䓬衍生物作为rsv抑制剂
WO2020210246A1 (en) 2019-04-09 2020-10-15 Enanta Pharmaceuticals, Inc, Heterocyclic compounds as rsv inhibitors
US11505558B1 (en) 2019-10-04 2022-11-22 Enanta Pharmaceuticals, Inc. Antiviral heterocyclic compounds
UY39032A (es) 2020-01-24 2021-07-30 Enanta Pharm Inc Compuestos heterocíclicos como agentes antivirales
WO2022010882A1 (en) 2020-07-07 2022-01-13 Enanta Pharmaceuticals, Inc, Dihydroquinoxaline and dihydropyridopyrazine derivatives as rsv inhibitors
US11945824B2 (en) 2020-10-19 2024-04-02 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as anti-viral agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3371085A (en) * 1959-12-10 1968-02-27 Hoffmann La Roche 5-aryl-3h-1,4-benzodiazepin-2(1h)-ones
JPS4426302Y1 (ru) * 1966-04-22 1969-11-05

Also Published As

Publication number Publication date
SE7510823L (sv) 1975-09-26
JPS5041886A (ru) 1975-04-16
SU528872A3 (ru) 1976-09-15
IE39904L (en) 1975-01-30
ES428675A1 (es) 1976-09-01
CA1021778A (en) 1977-11-29
FR2239464B1 (ru) 1978-04-14
US4010153A (en) 1977-03-01
AT337192B (de) 1977-06-10
IL45289A (en) 1979-12-30
HU169180B (ru) 1976-10-28
CH573928A5 (ru) 1976-03-31
FI227474A (ru) 1975-01-31
ZA744635B (en) 1975-08-27
SE7409708L (ru) 1975-01-31
DK138798B (da) 1978-10-30
AR202224A1 (es) 1975-05-23
ATA567674A (de) 1976-10-15
IL45289A0 (en) 1974-10-22
DK138798C (ru) 1979-04-09
IE39904B1 (en) 1979-01-31
NO137897B (no) 1978-02-06
DK393274A (ru) 1975-04-01
FR2239464A1 (ru) 1975-02-28
NO742739L (ru) 1975-02-24
DE2436744A1 (de) 1975-02-27
NL7410256A (nl) 1975-02-03
BE818047A (fr) 1974-11-18
GB1481219A (en) 1977-07-27

Similar Documents

Publication Publication Date Title
SE419981B (sv) Forfarande for framstellning av 1alfa-hydroxi-vitamin d-derivat
SE453667B (sv) Forfarande for framstellning av polyeterimider
NO142397C (no) Analogifremgangsmaate for fremstilling av 6,11-dihydro-11-oksodibenz (b,e)-oksepineddiksyrer
NO137897C (no) Fremgangsmaate til fremstilling av optisk aktive 1,4-benzdiazepin-2-on-derivater
SE435713B (sv) Forfarande for framstellning av 1,3-bensoxazoler
SE419750B (sv) Forfarande for framstellning av 6-acyl-2,4-dialkyl-2-hydroxicyklohexan-1,35-trion
SE420720B (sv) Forfarande for framstellning av 2,6-disubstuerade fenylaminoguanidinforeningar
SE7508074L (sv) Forfarande for framstellning av stilbenderivat.
SE420098B (sv) Forfarande for framstellning av linkomycinderivat
SE429237B (sv) Forfarande for framstellning av 9,3",4"-tri-alkanoyl sf-837 m,-derivat
SE419443B (sv) Forfarande for framstellning av nya 2,4 diamino-5-bensylpyrimidinderivat
SE421313B (sv) Forfarande for framstellning av 2-(fenoxialkyltio)-5-nitroimidazoler
NO138376C (no) Fremgangsmaate for fremstilling av 1-beta-d-ribofuranosyl-1, 2, 4-triazol-3-karboksamid
SE421129B (sv) Forfarande for framstellning av poly-n-alkyl-iminoalaner
SE419444B (sv) Forfarande for framstellning av nya 2,4-diamino-5-bensylpyrimidinderivat
SE402105B (sv) Forfarande for framstellning av 2-amino-5-alkyl-1,3,4-tiadiazoler
SE401835B (sv) Forfarande for framstellning av 17beta-hydroxi-16,16-dimetylest-4-en-3-on
SE415100B (sv) Forfarande for framstellning av kinuklidin-kinolinderivat
SE401833B (sv) Forfarande for framstellnig av vissa angivna 1,2,4-friazolderivat
SE417966B (sv) Forfarande for framstellning av pyrimidinoaminometyl-ergolinderivat
SE419980B (sv) Forfarande for framstellning av eventuellt substituerade 2-fenyl-bicyklo /2,2,2/okt-3-ylalkylaminer
SE418084B (sv) Forfarande for framstellning av 1,2,4-bensotiadiazin-derivat
SE413497B (sv) Forfarande for framstellning av alkaliperkarbonater.
SE413025B (sv) Forfarande for framstellning av nya 6,7-bensomorfanderivat
SE429653B (sv) Forfarande for framstellning av tiazotin - resp. tiazolderivat